Agilon Health, Inc. current report, 05 January 2024

Business Context and Reporting Period

Agilon health, inc. filed a Form 8-K dated January 5, 2024, under Items 5.02, 7.01, and 9.01. The filing concerns a planned senior management transition rather than quarterly or annual financial results.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes Versus Prior Comparable Period

  • Timothy Bensley informed the company of his intention to retire as Chief Financial Officer during 2024.
  • The company expects the retirement to occur within the nine months following January 5, 2024.
  • Agilon health has begun searching for a successor.
  • Mr. Bensley agreed to remain CFO during the search and to serve in a consulting role through the transition.

Guidance, Outlook, Risks, and Unusual Items

No financial guidance or operating outlook was provided. The primary disclosed matter is CFO succession. The timing of the retirement and appointment of a successor remains subject to the ongoing search and transition process.

The related press release was furnished as Exhibit 99.1 under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act, except as expressly provided by reference.

Investor Verification Items

  • Verify the timing of Mr. Bensley’s retirement and the identity and qualifications of the appointed successor.
  • Monitor whether the transition affects financial reporting, internal controls, forecasts, or previously issued guidance.
  • Review subsequent filings for the terms of any consulting arrangement or other compensation associated with the transition.